Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling

Brain, Behavior, and Immunity

Volumn 41, Issue 1, 2014, Pages 65-81

  Dellarole, Anna ^a   Morton, Paul ^a,e   Brambilla, Roberta ^a   Walters, Winston ^a   Summers, Spencer ^a   Bernardes, Danielle ^a,b   Grilli, Mariagrazia ^c   Bethea, John R ^a,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d DREXEL UNIVERSITY   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cytokines; Depression; Myelin; Neurogenesis; Neuropathic pain; Plasticity; TNF; TNFR1

Indexed keywords

BROXURIDINE; CORTICOSTERONE; DOUBLECORTIN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; MYELIN PROTEIN; NEUROMODULIN; PROTEOLIPID PROTEIN; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TNFRH2 PROTEIN, MOUSE; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ALLODYNIA; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DENTATE GYRUS; DEPRESSION; EXPERIMENTAL SCIATIC NERVE INJURY; FLUID INTAKE; HIPPOCAMPUS; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHIC PAIN; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUCROSE PREFERENCE TEST; SUGAR INTAKE; WEIGHT REDUCTION; WESTERN BLOTTING; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; DEFICIENCY; DRINKING BEHAVIOR; EXPLORATORY BEHAVIOR; FOOD PREFERENCE; GENETICS; HEAT; INJURIES; KNOCKOUT MOUSE; NEURALGIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; PSYCHOLOGY; SCIATIC NERVE; SCIATICA; SINGLE BLIND PROCEDURE;

ANHEDONIA; ANIMALS; CORTICOSTERONE; DEPRESSION; DRINKING BEHAVIOR; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; HIPPOCAMPUS; HOT TEMPERATURE; HYPERALGESIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURALGIA; NEUROGENESIS; NEURONAL PLASTICITY; PRESSURE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SCIATIC NERVE; SCIATICA; SIGNAL TRANSDUCTION; SINGLE-BLIND METHOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924076588     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.04.003     Document Type: Article

References (123)

1. Al-Amin H., Sarkis R., Atweh S., Jabbur S., Saadé N. Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: effects on brain cytokines and neurotrophins. Exp. Neurol. 2011, 228:30-40.
2. Aloisi A.M., Albonetti M.E., Muscettola M., Facchinetti F., Tanganelli C., Carli G. Effects of formalin-induced pain on ACTH, beta-endorphin, corticosterone and interleukin-6 plasma levels in rats. Neuroendocrinology 1995, 62:13-18.
3. Anisman H., Kokkinidis L., Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 2002, 16:544-556.
4. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
5. Bartzokis G. Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front. Biosci. (Landmark Ed) 2011, 16:2695-2733.
6. Arnett P.A., Barwick F.H., Beeney J.E. Depression in multiple sclerosis: review and theoretical proposal. J. Int. Neuropsychol. Soc. 2008, 14(5):691-724.
7. Arruda J.L., Sweitzer S., Rutkowski M.D., DeLeo J.A. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res. 2000, 879:216-225.
8. Balschun D., Wetzel W., Del Rey A., Pitossi F., Schneider H., Zuschratter W., Besedovsky H.O. Interleukin-6: a cytokine to forget. FASEB J. 2004, 18:1788-1790.
9. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001, 11(9):372-377.
10. Bedrosian T.A., Weil Z.M., Nelson R.J. Chronic dim light at night provokes reversible depression-like phenotype: possible role for TNF. Mol. Psychiatry 2012, 18:930-936.
11. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
12. Bessa J.M., Ferreira D., Melo I., Marques F., Cerqueira J.J., Palha J.A., Almeida O.F., Sousa N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol. Psychiatry 2009, 14:764-773.
13. Bianchi M., Di B., Panerai A.E. Interleukin-1 and nociception in the rat. J. Neurosci. Res. 1998, 53:645-650.
14. Biebl M., Cooper C.M., Winkler J., Kuhn H.G. Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci. Lett. 2000, 291:17-20.
15. Blaschke A.J., Staley K., Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996, 122:1165-1174.
16. Bos J.D., de Korte J. Effects of etanercept on quality of life, fatigue, and depression in psoriasis. Lancet 2006, 367(9504):6-7.
17. Bracchi-Ricard V., Lambertsen K.L., Ricard J., Nathanson L., Karmally S., Johnstone J., Ellman D.G., Frydel B., McTigue D.M., Bethea J.R. Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury. J. Neuroinflammation 2013, 10(1):92.
18. Brambilla R., Ashbaugh J.J., Magliozzi R., Dellarole A., Karmally S., Szymkowski D.E., Bethea J.R. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 2011, 134:2736-2754.
19. Brown J.P., Couillard-Despres S., Cooper-Kuhn C.M., Winkler J., Aigner L., Kuhn H.G. Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 2003, 467:1-10.
20. Cacci E., Claasen J.H., Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005, 80:789-797.
21. Caspani O., Zurborg S., Labuz D., Heppenstall P.A. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 2009, 4:e7383.
22. Castren E. Is mood chemistry?. Nat. Rev. Neurosci. 2005, 6:241-246.
23. Chen Z., Palmer T.D. Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis. Brain Behav. Immun. 2013, 30:45-53.
24. Cooper-Kuhn C.M., Kuhn H.G. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res. Dev. Brain Res. 2002, 134:13-21.
25. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
26. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
27. Dayas C.V., Buller K.M., Crane J.W., Xu Y., Day T.A. Stressor categorization: Acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci. 2001, 14:1143-1152.
28. Del Rey A., Yau H.J., Randolf A., Centeno M.V., Wildmann J., Martina M., Besedovsky H.O., Apkarian A.V. Chronic neuropathic pain-like behavior correlates with IL-1beta expression and disrupts cytokine interactions in the hippocampus. Pain 2011, 152:2827-2835.
29. Ducottet C., Griebel G., Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:625-631.
30. Duman R.S., Charney D.S. Cell atrophy and loss in major depression. Biol. Psychiatry 1999, 45:1083-1084.
31. Duric V., McCarson K.E. Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J. Pain 2006, 7:544-555.
32. Ertenli I., Ozer S., Kiraz S., Apras S.B., Akdogan A., Karadag O., Calguneri M., Kalyoncu U. Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol. Int. 2012, 32:323-330.
33. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 1999, 29(2):626-632.
34. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
35. Finsen B., Antel J., Owens T. TNFalpha: kill or cure for demyelinating disease?. Mol. Psychiatry 2002, 7:820-821.
36. Fu E.S., Zhang Y.P., Sagen J., Candiotti K.A., Morton P.D., Liebl D.J., Bethea J.R., Brambilla R. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 2010, 148:509-518.
37. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int. J. Neuropsychopharmacol. 2008, 11:49-61.
38. George A., Buehl A., Sommer C. Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci. Lett. 2004, 372:215-219.
39. Gleeson J.G., Lin P.T., Flanagan L.A., Walsh C.A. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999, 23:257-271.
40. Gonçalves L., Silva R., Pinto-Ribeiro F., Pêgo J.M., Bessa J.M., Pertovaara A., Sousa N., Almeida A. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp. Neurol. 2008, 213(1):48-56.
41. Gould E., Tanapat P., McEwen B.S., Flugge G., Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3168-3171.
42. Griebel G., Simiand J., Steiberg R., Jung M., Gull D., Roger P., Geslin M., Scatton B., Maffrand J.P., Soubrie P. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist: II. Characterization in rodent models of stress-related disorders. J. Pharmacol. Exp. Ther. 2002, 301:333-345.
43. Gross C.G. Neurogenesis in the adult brain: death of a dogma. Nat. Rev. Neurosci. 2000, 1:67-73.
44. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Dolan R.J., Critchley H.D. Neural origins of human sickness in interoceptive responses to inflammation. Biol. Psychiatry 2009, 66:415-422.
45. Harbuz M.S., Lightman S.L. Stress and the hypothalamopituitary-adrenal axis: acute, chronic and immunological activation. J. Endocrinol. 1992, 134:327-339.
46. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12(2):123-137.
47. Holtmann M.H., Neurath M.F. Differential TNF-signaling in chronic inflammatory disorders. Curr. Mol. Med. 2004, 4:439-444.
48. Honore P., Wade C.L., Zhong C., Harris R.R., Wu C., Ghayur T., Iwakura Y., Decker M.W., Faltynek C., Sullivan J., Jarvis M.F. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav. Brain Res. 2006, 167:355-364.
49. Hori T., Oka T., Hosoi M., Aou S. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann. N. Y. Acad. Sci. 1998, 840:269-281.
50. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.E., Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 2006, 26:9703-9712.
51. Ishikawa T., Miyagi M., Kamoda H., Orita S., Eguchi Y., Arai G., Suzuki M., Sakuma Y., Oikawa Y., Inoue G., Aoki Y., Toyone T., Takahashi K., Ohtori S. Differences between tumor necrosis factor-alpha receptors types 1 and 2 in the modulation of spinal glial cell activation and mechanical allodynia in a rat sciatic nerve injury model. Spine 2013, 38:11-16.
52. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R., Rodrigues A.L. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012, 62:419-426.
53. Kee N., Sivalingam S., Boonstra R., Wojtowicz J.M. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 2002, 115:97-105.
54. Kempermann G., Gage F.H. Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis. Brain Res. Dev. Brain Res. 2002, 134:1-12.
55. Kempermann G., Gast D., Kronenberg G., Yamaguchi M., Gage F.H. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 2003, 130:391-399.
56. Kempermann G., Jessberger S., Steiner B., Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004, 27:447-452.
57. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24-28.
58. Kodama D., Ono H., Tanabe M. Altered hippocampal long-term potentiation after peripheral nerve injury in mice. Eur. J. Pharmacol. 2007, 574:127-132.
59. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994, 77(3):325-328.
60. Kontinen V.K., Kauppila T., Paananen S., Pertovaara A., Kalso E. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 1999, 80(1-2):341-346.
61. Korgaonkar M.S., Grieve S.M., Koslow S.H., Gabrieli J.D., Gordon E., Williams L.M. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging. Hum. Brain Mapp. 2011, 32(12):2161-2171.
62. Kubera M., Maes M., Kenis G., Kim Y.K., Lason W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res. 2005, 134:251-258.
63. Kuzumaki N., Ikegami D., Imai S., Narita M., Tamura R., Yajima M., Suzuki A., Miyashita K., Niikura K., Takeshima H., Ando T., Ushijima T., Suzuki T., Narita M. Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse 2010, 64:721-728.
64. Norman G.J., Karelina K., Zhang N., Walton J.C., Morris J.S., Devries A.C. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol. Psychiatry 2010, 15:404-414.
65. Kyriakopoulos M., Perez-Iglesias R., Woolley J.B., Kanaan R.A., Vyas N.S., Barker G.J., Frangou S., McGuire P.K. Effect of age at onset of schizophrenia on white matter abnormalities. Br. J. Psychiatry 2009, 195:346-353.
66. Lindenlaub T., Teuteberg P., Hartung T., Sommer C. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 2000, 866:15-22.
67. Liu J., Dietz K., DeLoyht J.M., Pedre X., Kelkar D., Kaur J., Vialou V., Lobo M.K., Dietz D.M., Nestler E.J., Dupree J., Casaccia P. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat. Neurosci. 2012, 15(12):1621-1623.
68. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., Bruck W., Parisi J.E., Scheithauer B.W., Giannini C., Weigand S.D., Mandrekar J., Ransohoff R.M. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 2011, 365:2188-2197.
69. MacEwan D.J. TNF ligands and receptors-a matter of life and death. Br. J. Pharmacol. 2002, 135:855-875.
70. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Front. Biosci. (Landmark Ed) 2009, 14:5291-5338.
71. Mangiardi M., Crawford D.K., Xia X., Du S., Simon-Freeman R., Voskuhl R.R., Tiwari-Woodruff S.K. An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol. 2011, 21:263-278.
72. Martinez T.N., Chen X., Bandyopadhyay S., Merrill A.H., Tansey M.G. Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons. Mol. Neurodegener. 2012, 7:45.
73. Martuscello R.T., Spengler R.N., Bonoiu A.C., Davidson B.A., Helinski J., Ding H., Mahajan S., Kumar R., Bergey E.J., Knight P.R., Prasad P.N., Ignatowski T.A. Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptoms. Pain 2012, 153:1871-1882.
74. Matsuzawa-Yanagida K., Narita M., Nakajima M., Kuzumaki N., Niikura K., Nozaki H., Takagi T., Tamai E., Hareyama N., Terada M., Yamazaki M., Suzuki T. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology 2008, 33(8):1952-1965.
75. McWilliams L.A., Cox B.J., Enns M.W. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003, 106:127-133.
76. Merkler D., Ernsting T., Kerschensteiner M., Bruck W., Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 2006, 129:1972-1983.
77. Merkler D., Klinker F., Jurgens T., Glaser R., Paulus W., Brinkmann B.G., Sereda M.W., Stadelmann-Nessler C., Guedes R.C., Bruck W., Liebetanz D. Propagation of spreading depression inversely correlates with cortical myelin content. Ann. Neurol. 2009, 66:355-365.
78. Mettenburg J.M., Benzinger T.L., Shimony J.S., Snyder A.Z., Sheline Y.I. Diminished performance on neuropsychological testing in late life depression is correlated with microstructural white matter abnormalities. Neuroimage 2012, 60(4):2182-2190.
79. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur. Neuropsychopharmacol. 2001, 11:203-208.
80. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
81. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
82. Mutso A.A., Radzicki D., Baliki M.N., Huang L., Banisadr G., Centeno M.V., Radulovic J., Martina M., Miller R.J., Apkarian A.V. Abnormalities in hippocampal functioning with persistent pain. J. Neurosci. 2012, 32:5747-5756.
83. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science 1993, 259(5102):1769-1771.
84. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
85. O'Connor J.C., Lawson M.A., Andre C., Briley E.M., Szegedi S.S., Lestage J., Castanon N., Herkenham M., Dantzer R., Kelley K.W. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J. Immunol. 2009, 182:3202-3212.
86. Pan W., Kastin A.J. Increase in TNFα transport after SCI is specific for time, region, and type of lesion. Exp. Neurol. 2001, 170:357-363.
87. Pan W., Kastin A.J. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Exp. Neurol. 2002, 174:193-200.
88. Pan W., Ding Y., Yu Y., Ohtaki H., Nakamachi T., Kastin A.J. Stroke upregulates TNFα transport across the blood-brain barrier. Exp. Neurol. 2006, 198:222-233.
89. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Krönke M., Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell 1993, 73:457-467.
90. Probert L., Eugster H.P., Akassoglou K., Bauer J., Frei K., Lassmann H., Fontana A. TNFR1 signaling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 2000, 123:2005-2019.
91. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
92. Reinés A., Cereseto M., Ferrero A., Sifonios L., Podestà M.F., Wikinski S. Maintenance treatment with fluoxetine is necessary to sustain normal levels of synaptic markers in an experimental model of depression: correlation with behavioural response. Neuropsycolpharmacology 2008, 33:1896-1908.
93. Ren K., Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res. Rev. 2009, 60:57-64.
94. Ren W.J., Liu Y., Zhou L.J., Li W., Zhong Y., Pang R.P., Xin W.J., Wei X.H., Wang J., Zhu H.Q., Wu C.Y., Qin Z.H., Liu G., Liu X.G. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-alpha in rodents. Neuropsychopharmacology 2011, 36:979-992.
95. Reynolds J.L., Ignatowski T.A., Sud R., Spengler R.N. Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant. J. Pharmacol. Exp. Ther. 2004, 310:1216-1225.
96. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007, 10:1110-1115.
97. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression?. Biol. Psychiatry 2004, 56:137-139.
98. Schafers M., Schmidt C., Vogel C., Toyka K.V., Sommer C. Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathol. 2002, 104:197-205.
99. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000, 182:311-322.
100. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
101. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
102. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
103. Sommer C., Schafers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 1998, 784:154-162.
104. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
105. Strekalova T., Spanagel R., Dolgov O., Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav. Pharmacol. 2005, 16:171-180.
106. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav. Pharmacol. 2006, 17:271-287.
107. Strekalova T., Steinbusch H.W. Measuring behavior in mice with chronic stress depression paradigm. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:348-361.
108. Taoufik E., Tseveleki V., Chu S.Y., Tselios T., Karin M., Lassmann H., Szymkowski D.E., Probert L. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. Brain 2011, 134:2722-2735.
109. Tuglu C., Kara S.H., Caliyurt O., Vardar E., Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003, 1(70):429-433.
110. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R., Cella D., Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
111. Vogel C., Stallforth S., Sommer C. Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J. Peripher. Nerv. Syst. 2006, 11:294-303.
112. Wajant H., Scheurich P. TNFR1-induced activation of the classical NF-κB pathway. FEBS J. 2011, 278(6):862-876.
113. Walsh R.N., Cummings R.A. The open field test: a critical review. Psycol. Bull. 1976, 83:482-504.
114. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16:239-249.
115. Watanabe Y., Gould E., McEwen B.S. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 1992, 588:341-345.
116. Willner P., Moreau J.L., Nielsen C.K., Papp M., Sluzewska A. Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol. Behav. 1996, 60:129-134.
117. Yalcin I., Bohren Y., Waltisperger E., Sage-Ciocca D., Yin J.C., Freund-Mercier M.J., Barrot M. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol. Psychiatry 2011, 70:946-953.
118. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711:163-174.
119. Yirmiya R., Weidenfeld J., Pollak Y., Morag M., Morag A., Avitsur R., Barak O., Reichenberg A., Cohen E., Shavit Y., Ovadia H. Cytokines, "depression due to a general medical condition", and antidepressant drugs. Adv. Exp. Med. Biol. 1999, 461:283-316.
120. Zeng L.L., Liu L., Liu Y., Shen H., Li Y., Hu D. Antidepressant treatment normalizes white matter volume in patients with major depression. PLoS One 2012, 7(8):44248.
121. Zhang Y.P., Fu E.S., Sagen J., Levitt R.C., Candiotti K.A., Bethea J.R., Brambilla R. Glial NF-kappaB inhibition alters neuropeptide expression after sciatic nerve injury in mice. Brain Res. 2011, 1385:38-46.
122. Zhang R., He J., Zhu S., Zhang H., Wang H., Adilijiang A., Kong L., Wang J., Kong J., Tan Q., Li X.M. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia. Brain Res. 2012, 1469:136-143.
123. Zhang H., Zhang H., Dougherty P.M. Dynamic effects of TNF-alpha on synaptic transmission in mice over time following sciatic nerve chronic constriction injury. J. Neurophysiol. 2013, 110:1663-1671.